Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism

被引：0
|
作者：
Heike Corda
Sebastian Kummer
Alena Welters
Norbert Teig
Dirk Klee
Ertan Mayatepek
Thomas Meissner
机构：
[1] University Children’s Hospital Duesseldorf,Department of General Pediatrics, Neonatology and Pediatric Cardiology
[2] University Children’s Hospital,Department of Diagnostic and Interventional Radiology, Medical Faculty
[3] Katholisches Klinikum,undefined
[4] Ruhr-Universität Bochum,undefined
[5] University Duesseldorf,undefined
来源：
Orphanet Journal of Rare Diseases | / 12卷
关键词：
Congenital hyperinsulinism; Beckwith-Wiedemann syndrome; Hyperinsulinaemic hypoglycaemia; Somatostatin analogue; Adverse event;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism
    Corda, Heike
    Kummer, Sebastian
    Welters, Alena
    Teig, Norbert
    Klee, Dirk
    Mayatepek, Ertan
    Meissner, Thomas
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [2] Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly
    Caron, P
    Beckers, A
    Cullen, DR
    Goth, MI
    Gutt, B
    Laurberg, P
    Pico, AM
    Valimaki, M
    Zgliczynski, W
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01): : 99 - 104
  • [3] Efficacy of the new long-acting formulation of lanreotide (Lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly
    G. Lombardi
    F. Minuto
    G. Tamburrano
    M. R. Ambrosio
    G. Arnaldi
    M. Arosio
    V. Chiarini
    R. Cozzi
    S. Grottoli
    F. Mantero
    F. Bogazzi
    M. Terzolo
    P. Tita
    P. F. Boscani
    A. Colao
    Journal of Endocrinological Investigation, 2009, 32 : 202 - 209
  • [4] Efficacy of the new long-acting formulation of lanreotide (Lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly
    Lombardi, G.
    Minuto, F.
    Tamburrano, G.
    Ambrosio, M. R.
    Arnaldi, G.
    Arosio, M.
    Chiarini, V.
    Cozzi, R.
    Grottoli, S.
    Mantero, F.
    Bogazzi, F.
    Terzolo, M.
    Tita, P.
    Boscani, P. F.
    Colao, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (03): : 202 - 209
  • [5] The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel
    A. Bianchi
    L. De Marinis
    A. Fusco
    F. Lugli
    L. Tartaglione
    D. Milardi
    M. Mormando
    A. P. Lassandro
    R. Paragliola
    C. A. Rota
    S. Della Casa
    S. M. Corsello
    M. G. Brizi
    A. Pontecorvi
    Journal of Endocrinological Investigation, 2011, 34 : 692 - 697
  • [6] The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel
    Bianchi, A.
    De Marinis, L.
    Fusco, A.
    Lugli, F.
    Tartaglione, L.
    Milardi, D.
    Mormando, M.
    Lassandro, A. P.
    Paragliola, R.
    Rota, C. A.
    Della Casa, S.
    Corsello, S. M.
    Brizi, M. G.
    Pontecorvi, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (09) : 692 - 697
  • [7] Treatment of Congenital Hyperinsulinism with Lanreotide Acetate (Somatuline Autogel)
    Modan-Moses, Dalit
    Koren, Ilana
    Mazor-Aronovitch, Kineret
    Pinhas-Hamiel, Orit
    Landau, Heddy
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (08): : 2312 - 2317
  • [8] Four-year follow-up of acromegalic patients treated with the new long-acting formulation of lanreotide (Lanreotide Autogel)
    Gutt, B
    Bidlingmaier, M
    Kretschmar, K
    Dieterle, C
    Steffin, B
    Schopohl, J
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (03) : 139 - 144
  • [9] Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors
    Ricci, S
    Antonuzzo, A
    Galli, L
    Orlandini, C
    Ferdeghini, M
    Boni, G
    Roncella, M
    Mosca, F
    Conte, PF
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04): : 412 - 415
  • [10] Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients
    van Thiel, SW
    Romijn, JA
    Biermasz, NR
    Ballieux, BEPM
    Frölich, M
    Smit, JWA
    Corssmit, EPM
    Roelfsema, F
    Pereira, AM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (04) : 489 - 495
12345